CareDx (CDNA) Tops Q1 EPS by 21c; Withdraws Guidance

Go back to CareDx (CDNA) Tops Q1 EPS by 21c; Withdraws Guidance

BTIG Downgrades CareDx, Inc (CDNA) to Neutral 'Given various uncertainties'

May 11, 2023 6:14 AM EDT

BTIG analyst Sung Ji Nam downgraded CareDx, Inc (NASDAQ: CDNA) from Buy to Neutral.

The analyst comments "CareDx announced on its Q1 call that they are withdrawing its guidance, which is more Draconian than we called for in our preview for CDNA to... More